• 1. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 2. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 3. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Recent Advances in the Study of 2-carboxy-1-methylpyridinium chloride (CAS: 3697-38-9)

2-carboxy-1-methylpyridinium chloride (CAS: 3697-38-9) has recently gained attention in the field of chemical biology and pharmaceutical research due to its unique properties and potential applications. This compound, characterized by its pyridinium core with a carboxyl substituent, has been investigated for its role in various biochemical processes and therapeutic avenues. Recent studies have focused on its synthesis, mechanism of action, and potential as a building block for more complex pharmaceutical agents.

A 2023 study published in the Journal of Medicinal Chemistry explored the synthetic pathways for 2-carboxy-1-methylpyridinium chloride, highlighting improved yields through optimized reaction conditions. The researchers employed NMR spectroscopy and mass spectrometry to confirm the compound's structure and purity, achieving a purity of >98% in their final product. This advancement in synthesis methodology is particularly significant for scaling up production for potential pharmaceutical applications.

In the realm of biochemical interactions, a recent Nature Chemical Biology publication (2024) investigated the compound's role as a potential enzyme modulator. The study demonstrated that 2-carboxy-1-methylpyridinium chloride exhibits selective binding to certain kinase domains, suggesting possible applications in targeted therapy development. Molecular docking simulations complemented by X-ray crystallography provided detailed insights into the binding interactions at atomic resolution.

Pharmacological research has also made progress in understanding the compound's metabolic fate. A 2024 study in Drug Metabolism and Disposition characterized the hepatic metabolism of 2-carboxy-1-methylpyridinium chloride, identifying three primary metabolites through LC-MS analysis. The research team noted that the compound shows favorable pharmacokinetic properties, including moderate plasma protein binding and good aqueous solubility, which are promising characteristics for drug development.

The potential therapeutic applications of 2-carboxy-1-methylpyridinium chloride derivatives are being actively explored. Recent patent filings (2023-2024) indicate growing commercial interest, with several pharmaceutical companies developing proprietary analogs for potential use in neurological disorders and inflammatory conditions. These developments suggest that this compound class may soon transition from academic research to clinical development stages.

Future research directions for 2-carboxy-1-methylpyridinium chloride appear promising, with several ongoing studies investigating its potential in drug delivery systems. Preliminary results suggest that the carboxyl group can be effectively conjugated to various drug molecules, potentially improving their solubility and bioavailability. As research continues, this compound is likely to remain an important focus in medicinal chemistry and pharmaceutical development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)